Results 111 to 120 of about 9,301 (205)

Raltegravir‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety [PDF]

, 2010
Meo Perry, Noor Almaani, Nemesha Desai, Julie Fox, N Larbalestier, Daniella Chilton   +5 more
openalex   +1 more source

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

, 2010
Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, Ellen S. Chan, David M. Margolis, Sarah Read, Beatrice Kallungal, Sarah Palmer, Kathy Medvik, Michael M. Lederman, Nadia Alatrakchi, Jeffrey M. Jacobson, Ann Wiegand, Mary F. Kearney, John M. Coffin, John W. Mellors, Joseph J. Eron   +16 more
openalex   +4 more sources

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]

Int J Mol Sci
Gáspár Z, Lakatos B.
europepmc   +1 more source

Analysis of raltegravir analogs to enhance inhibitory efficiency against HIV integrase. [PDF]

Sci Rep
Sabaghian H, Yoosefian M.
europepmc   +1 more source

Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?

, 2009
Amedeo Capetti, Stefania Piconi, Simona Landonio, Giuliano Rizzardini, Carlo Federico Perno   +4 more
openalex   +1 more source

The transmembrane nucleoporin Nup210 weakens HIV-1 infection via modulating late events of viral nuclear import. [PDF]

AIDS
Wang L, Li SM, Li X, Wu HS, Ma C, Wang DB, Zhang XE.   +6 more
europepmc   +1 more source

Raltegravir With Unboosted Atazanavir 300 mg Twice Daily in Antiretroviral Treatment-Experienced Participants

, 2009
Shaili Gupta, Max Lataillade, Steven Farber, Michael J. Kozal   +3 more
openalex   +1 more source

Use of once‐daily raltegravir‐based HAART in HIV‐infected injection drug users [PDF]

, 2010
HK Tossonian, JD Raffa, O Alenezi, Kevin W. Anderson, Sara Jassemi, K Wight, Stanley DeVlaming, Barbara R. Conway   +7 more
openalex   +1 more source

Correction: Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. [PDF]

Paediatr Drugs
Kamphuis AEM, Bamford A, Tagarro A, Cressey TR, Bekker A, Amuge P, Mujuru HA, Ndongo FA, Diack A, Compagnucci A, Lallemant M, Colbers A, Turkova A.   +12 more
europepmc   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Chen M, Gandhi-Patel B, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Scerpella EG, Chaudhari P, Jarrett J.   +10 more
europepmc   +1 more source